NLRP3 and non-small cell lung carcinoma: Given that NLRP3 could be negatively regulated by miR-556-5p [43], we next verified that knockdown of miR-556-5p increased cisplatin-sensitivity by re-activating NLRP3-mediated cell pyroptosis in CR-NSCLC cells.